SIRDALUD MR caps ret 6 mg 30 pce

7680489790178 CH-48979 M03BX02 01.12.0.
SIRDALUD MR caps ret 6 mg 30 pce
SIRDALUD MR caps ret 6 mg 30 pce
SIRDALUD MR caps ret 6 mg 30 pce
1 / 3
google

Details

Product number
4897901
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
tizanidinum 6 mg ut tizanidini hydrochloridum, maydis amylum, saccharum 124.3-142.2 mg, aqua purificata, ethylcellulosum, lacca, talcum, gelatina, E 171, E 172 (nigrum), pro capsula.

Articles (1)

Sirdalud MR 6 mg, Hartkapseln, retardiert
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 32.60
Specialties list
Yes
Generic
No
SL addition date: 15/03/1989

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
48979
Drug name
Sirdalud MR, Hartkapseln, retardiert
Galenic form
RETH
ATC Code
M03BX02
Authorization status
Z
Dispensation category
B
First authorization
06/06/1988
Authorization expiration date
31/12/9999
IT number
01.12.0.
Domain
Human medicine
Field of application
Myotonolyticum

Packaging details

Description (FR)
SIRDALUD MR caps ret 6 mg 30 pce
Description (DE)
SIRDALUD MR Ret Kaps 6 mg 30 Stk
Market launch
06/06/1988
Narcotic (BTM)
No

Available generics

Tizanidin axapharm, Tabletten
CHF 14.25
View
Tizanidin axapharm, Tabletten
CHF 30.80
View
Tizanidin axapharm, Tabletten
CHF 12.40
View
Tizanidin axapharm, Tabletten
CHF 17.15
View
Tizanidin axapharm, Tabletten
CHF 41.55
View

Other packaging sizes